Literature DB >> 16830364

Changes of inducible protein-10 and regulated upon activation, normal T cell expressed and secreted protein in acute rejection of pancreas transplantation in rats.

Jun Zhu1, Ze-Kuan Xu, Yi Miao, Xun-Liang Liu, Hong Zhang.   

Abstract

AIM: To investigate the role of IFN-gamma inducible protein -10 (IP-10) and regulated upon activation, normal T cell expressed and secreted (RANTES) protein in acute pancreatic allograft rejection in rats.
METHODS: An experimental pancreas transplantation model was established using diabetic SD rats as the recipient, induced by applying streptozocin (STZ). Pancreas transplantation was performed with a physiologic method of portal venous and enteric drainage. Rats were divided into two groups, isograft group (group A, n = 24) and allograft group (group B, n = 24) in which either healthy SD rats or Wistar rats served as donors, respectively. Twelve diabetic or healthy SD rats were used as controls. At d 1, 4, 7, and 10 post transplantation, serum IP-10 and RANTES were assessed by ELISA and their expression in the allografts was determined by immunohistochemistry.
RESULTS: In group B (allograft group), the development of acute rejection was significantly correlated with increased serum concentration and tissue expression of IP-10 and RANTES, with a peak level at d 7 post transplantation. In contrast, there was no obvious change before and after transplantation in group A (isograft group).
CONCLUSION: Our study suggests a possible role of IP-10 and RANTES in acute rejection and early monitoring of chemokines may be helpful in predicting the outcome of pancreas transplantation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16830364      PMCID: PMC4087363          DOI: 10.3748/wjg.v12.i26.4156

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  16 in total

1.  RANTES in the postoperative course after liver transplantation.

Authors:  M Schenk; A Zipfel; C Schulz; H D Becker; R Viebahn
Journal:  Transpl Int       Date:  2000       Impact factor: 3.782

Review 2.  Chemokines, chemokine receptors, and allograft rejection.

Authors:  P J Nelson; A M Krensky
Journal:  Immunity       Date:  2001-04       Impact factor: 31.745

Review 3.  Multiple pathways to allograft rejection.

Authors:  Alain Le Moine; Michel Goldman; Daniel Abramowicz
Journal:  Transplantation       Date:  2002-05-15       Impact factor: 4.939

4.  Rantes production during development of cardiac allograft vasculopathy.

Authors:  J J Yun; M P Fischbein; H Laks; Y Irie; M L Espejo; M C Fishbein; J A Berliner; A Ardehali
Journal:  Transplantation       Date:  2001-06-15       Impact factor: 4.939

5.  Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection.

Authors:  M Melter; A Exeni; M E Reinders; J C Fang; G McMahon; P Ganz; W W Hancock; D M Briscoe
Journal:  Circulation       Date:  2001-11-20       Impact factor: 29.690

6.  Monocyte chemoattractant protein-1 and RANTES are chemotactic for graft infiltrating lymphocytes during acute lung allograft rejection.

Authors:  Y Sekine; K Yasufuku; K M Heidler; O W Cummings; N Van Rooijen; T Fujisawa; J Brown; D S Wilkes
Journal:  Am J Respir Cell Mol Biol       Date:  2000-12       Impact factor: 6.914

7.  Role of RANTES in experimental cardiac allograft rejection.

Authors:  M S Mulligan; J E McDuffie; T P Shanley; R F Guo; J Vidya Sarma; R L Warner; P A Ward
Journal:  Exp Mol Pathol       Date:  2000-12       Impact factor: 3.362

8.  Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection.

Authors:  C Agostini; F Calabrese; F Rea; M Facco; A Tosoni; M Loy; G Binotto; M Valente; L Trentin; G Semenzato
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

9.  Surveillance of acute rejection in baboon renal transplantation by elevation of interferon-gamma inducible protein-10 and monokine induced by interferon-gamma in urine.

Authors:  Turan Kanmaz; Ping Feng; Jose Torrealba; Jean Kwun; John H Fechner; Jacqueline M Schultz; Yinchen Dong; Hyoung Tae Kim; Wasim Dar; Majed M Hamawy; Stuart J Knechtle; Huaizhong Hu
Journal:  Transplantation       Date:  2004-10-15       Impact factor: 4.939

10.  Correlation of rejection of the duodenum with rejection of the pancreas in a pig model of pancreaticoduodenal transplantation.

Authors:  R E Nakhleh; D E Sutherland; P Tzardis; R Schechner; R W Gruessner
Journal:  Transplantation       Date:  1993-12       Impact factor: 4.939

View more
  3 in total

1.  Promise of endothelial progenitor cell for treatment of diabetic retinopathy.

Authors:  Ashay D Bhatwadekar; Lynn C Shaw; Maria B Grant
Journal:  Expert Rev Endocrinol Metab       Date:  2010-01

2.  Endothelial progenitor dysfunction in the pathogenesis of diabetic retinopathy: treatment concept to correct diabetes-associated deficits.

Authors:  Sergio Li Calzi; Matthew B Neu; Lynn C Shaw; Maria B Grant
Journal:  EPMA J       Date:  2010-03-01       Impact factor: 6.543

3.  The immunosuppressant Protosappanin A diminished recipient T cell migration into allograft via inhibition of IP-10 in rat heart transplant.

Authors:  Maomao Zhang; Jieqiong He; Jingbo Hou; Jian Wu; Meng Sun; Jinjin Cui; Jiangtian Tian; Miaomiao Jiang; Bo Yu
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.